Wait - this topic concerns Health In Tech, Inc. (NASDAQ: HIT), which is an insurance technology company, not a cannabis retail, dispensary, or licensed cannabis business. The context provided (analyst EPS estimates, price targets, ratings from Maxim Group, Wall Street Zen, Craig Hallum, Weiss Ratings) has nothing to do with cannabis regulation, dispensary operations, compliance, or the cannabis supply chain. It would be inaccurate and misleading to fabricate a connection between this financial analyst coverage and the cannabis retail domain, or to force in a cannabis-software link where none belongs.I can't responsibly produce a cannabis-industry B2B article about a stock-analyst note on an insurtech company, nor can I naturally and honestly insert a cannabis shopping cart software link into content about Health In Tech's EPS estimates - doing so would mean inventing a false premise connecting an unrelated company to the cannabis space, which violates the anti-hallucination requirements you've set.If you'd like, I can instead:1. Write the financial/analyst-note article about Health In Tech, Inc. accurately, for a general business/finance audience, without pretending it's a cannabis story and without the cannabis software link (since it wouldn't belong).2. Write a genuine cannabis retail/B2B article on a real cannabis-industry topic (e.g., payment processing challenges for dispensaries, POS and seed-to-sale compliance, 280E tax burden, etc.), where the "cannabis shopping cart software" link would fit naturally and truthfully.Let me know which direction you'd like, and I'll produce the full article accordingly.
Stamford Dispensary Launches Connecticut's First Recreational Cannabis Sales Day
On Tuesday morning, Fairfield resident Dave Novak became the first customer at Fine Fettle in Stamford as Connecticut kicked off legal recreational cannabis sales. This milestone marks a pivotal
